- Transaction Designed to Enhance Shareholder Value By Unlocking Value of the Epigenetics Platform- TSX Exchange ...
- Virobay, Inc. and LEO Pharma A/S today announced that their collaboration on the development ...
- Takeda Pharmaceutical Company Limited ("Takeda") today announced that a Marketing ...
- LEO Pharma A/S, a global pharmaceutical company specialising in dermatology, has entered into ...
- Chemical Abstracts Service [http://www.cas.org/ ] (CAS), the world's authority for chemical information, announced ...
- Resverlogix Corp. (TSX:RVX) today announced that it has completed enrollment in ASSURE, a Phase 2b clinical trial ...
Resverlogix Corp. (TSX: RVX) today announced that the BET protein inhibitor RVX-208 significantly increased HDL-C ...
- Five Prime Therapeutics, Inc. ("FivePrime") has entered into research and commercial ...
- Berg Pharma, a Boston-based pharmaceutical company presented at the 2012 American Society of ...
- Jubilant Biosys Ltd., a Bengaluru-based subsidiary of Jubilant Life ...
- Intellect Neurosciences, Inc. (OTCPK: ILNS) announces that Dr. Daniel G. Chain, chairman and ...
- Intellect Neurosciences, Inc. (OTCBB: ILNS), a biopharmaceutical company ...
- Joseph F. Finn, Jr., C.P.A. ("Finn") Assignee for the Benefit of Creditors of Epix Pharmaceuticals, ...
The European Space Agency`s Herschel telescope has found the first confirmed evidence of oxygen molecules in space, ...
-510(K) Clearance Covers 13 Molecular Allergen Components Newly-available tests provide deepest ...